Michael Paulzen
Overview
Explore the profile of Michael Paulzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Gillessen M, Schmidt C, Deligiannidis K, Kittel-Schneider S, Seifritz E, Tomson T, et al.
Expert Opin Drug Metab Toxicol
. 2025 Feb;
:1-10.
PMID: 39964299
Introduction: Our aim was to quantify the impact of menstrual cycle phases on the pharmacokinetics of antiseizure medications (ASM) and lithium. Methods: A systematic literature search was conducted in PubMed/EMBASE...
3.
4.
Gillessen F, Gaebler A, Haen E, Schoretsanitis G, Wozniak J, Stingl J, et al.
Expert Rev Clin Pharmacol
. 2024 Oct;
:1-8.
PMID: 39360663
Objective: We aimed to investigate the ambiguous findings of earlier research regarding the reduction of quetiapine plasma levels when combined with lamotrigine, most likely via UDP-glucuronosyltransferase induction by lamotrigine. Methods:...
5.
Watermeyer F, Gaebler A, Neuner I, Haen E, Hiemke C, Schoretsanitis G, et al.
Br J Clin Pharmacol
. 2024 Jul;
90(11):2793-2801.
PMID: 38970468
Aims: Metamizole is quite an old drug with analgesic, antipyretic and spasmolytic properties. Recent findings have shown that it may induce several cytochrome P450 (CYP) enzymes, especially CYP3A4 and CYP2B6....
6.
Hart X, Grunder G, Ansermot N, Conca A, Corruble E, Crettol S, et al.
World J Biol Psychiatry
. 2024 Jun;
25(9):451-536.
PMID: 38913780
Background: For psychotic disorders (i.e. schizophrenia), pharmacotherapy plays a key role in controlling acute and long-term symptoms. To find the optimal individual dose and dosage strategy, specialised tools are used....
7.
Schoretsanitis G, Deligiannidis K, Kasperk N, Schmidt C, Kittel-Schneider S, Ter Horst P, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2024 May;
133:111030.
PMID: 38762161
Objective: Increasing evidence suggests that the physiological changes of pregnancy may impact pharmacokinetics of antiseizure medications (ASM), and this may affect treatment outcomes. The aim of this study was to...
8.
Kuzin M, Haen E, Kuzo N, Endres K, Hiemke C, Paulzen M, et al.
Ther Drug Monit
. 2024 Feb;
46(2):246-251.
PMID: 38377253
Background: To assess the pharmacokinetic correlates of reported adverse drug reactions (ADRs) under antidepressant treatment with escitalopram (ESC) using a large therapeutic drug monitoring database. Methods: A large naturalistic sample...
9.
Kasperk N, Haen E, Hiemke C, Frodl T, Schoretsanitis G, Paulzen M, et al.
Expert Rev Clin Pharmacol
. 2024 Feb;
17(3):247-253.
PMID: 38299560
Objective: We assessed pharmacokinetic correlates of treatment response to escitalopram using a large therapeutic drug monitoring database. Methods: A large naturalistic sample of patients receiving escitalopram was analyzed. Responders were...
10.
Paulzen M, Schoretsanitis G
Nervenarzt
. 2023 Jul;
94(9):786-798.
PMID: 37460797
The medicinal treatment of mental disorders during pregnancy and lactation requires special knowledge about possible effects of the psychopharmacotherapy on the intrauterine exposure of the embryo/fetus. Therefore, the first part...